|
PUS7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99684713209081E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.35993471828533E-12 |
| Normal-vs-Stage2 |
3.527200E-01 |
| Normal-vs-Stage3 |
3.6928016200477E-11 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
5.582000E-03 |
| Stage1-vs-Stage3 |
7.991200E-01 |
| Stage1-vs-Stage4 |
4.019200000005E-05 |
| Stage2-vs-Stage3 |
5.720600E-03 |
| Stage2-vs-Stage4 |
1.577280E-04 |
| Stage3-vs-Stage4 |
7.282100E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-14 |
| Normal-vs-AfricanAmerican |
1.97559968384553E-10 |
| Normal-vs-Asian |
1.57080015661393E-10 |
| Caucasian-vs-AfricanAmerican |
1.912810E-01 |
| Caucasian-vs-Asian |
3.889000E-01 |
| AfricanAmerican-vs-Asian |
7.915400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52269996611665E-09 |
| Normal-vs-Female |
1.9506618542664E-12 |
| Male-vs-Female |
9.997200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.01758618093118E-12 |
| Normal-vs-Age(41-60Yrs) |
2.70619970876851E-10 |
| Normal-vs-Age(61-80Yrs) |
3.50819999994645E-06 |
| Normal-vs-Age(81-100Yrs) |
1.316460E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.881600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.039600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.650400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.266050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.469800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.846600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.923000E-03 |
| Classical-VS-Follicular |
2.648900E-04 |
| Classical-VS-Other |
6.910000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.11660000001734E-06 |
| Tall-VS-Other |
4.628000E-01 |
| Tall-VS-Normal |
5.37347943918576E-14 |
| Follicular-VS-Other |
1.208230E-02 |
| Follicular-VS-Normal |
6.419700E-03 |
| Other-VS-Normal |
6.413200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7565999987923E-08 |
| Normal-vs-N1 |
1.53432822003197E-13 |
| N0-vs-N1 |
1.100340E-03 |
|
|
